We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Exercise Time in Sedentary Middle-aged Female

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01851837
First Posted: May 13, 2013
Last Update Posted: February 20, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Mohammadreza Rezaeipour, MD, PhD, University of Sistan and Baluchestan
  Purpose
The exercise time is an important factor among the medical guides for weight loss; however, there is still little knowledge about exercise duration paths in middle-aged and older women. The present study aimed to determine the effects of the interval training on weight loss and lipid profile, and to compare its efficiency with the continuous training.

Condition Intervention
Weight Loss Other: Exercise time

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Response Of Weight And Lipid Profile To Exercise Time In Sedentary Overweight/Obese Middle-Aged And Older Women

Resource links provided by NLM:


Further study details as provided by Mohammadreza Rezaeipour, MD, PhD, University of Sistan and Baluchestan:

Primary Outcome Measures:
  • HDL-c [ Time Frame: 3 month ]

Enrollment: 115
Study Start Date: September 2012
Study Completion Date: March 2016
Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Group I
Study group I (57 participants) received the continuous training of exercise time.
Other: Exercise time
Continuous training, Interval training
Active Comparator: Group II
Study group II (58 participants) received the interval training of exercise time.
Other: Exercise time
Continuous training, Interval training

Detailed Description:
Participants included sedentary women (age 45-75 years) with overweight or obesity (n= 115). They were randomly divided into two groups including continuous exercise, and interval exercise. The weight assessment parameters including change in weight and body composition, blood sample tests were performed pre- and three month post-intervention.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   45 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Sedentary lifestyle
  • Good Health
  • Weight stability

Exclusion Criteria:

*Abnormality or history of Disease

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01851837


Sponsors and Collaborators
P.L.Shupik National Medical Academy of Post-Graduate Education
Investigators
Principal Investigator: Mohammadreza Rezaeipour, M.D. Member of Scientific Board in Physical Education and Sport Sciences
  More Information

Responsible Party: Mohammadreza Rezaeipour, MD, PhD, Assistant professor, University of Sistan and Baluchestan
ClinicalTrials.gov Identifier: NCT01851837     History of Changes
Other Study ID Numbers: no grant
First Submitted: May 4, 2013
First Posted: May 13, 2013
Last Update Posted: February 20, 2017
Last Verified: May 2016

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Weight Loss
Body Weight Changes
Body Weight
Signs and Symptoms